Published in J Bacteriol on March 01, 1978
Chromosomal genetics of Pseudomonas. Microbiol Rev (1979) 13.65
Extension of the host range of Escherichia coli vectors by incorporation of RSF1010 replication and mobilization functions. J Bacteriol (1985) 2.70
Cloning of genes for naphthalene metabolism in Pseudomonas putida. J Bacteriol (1983) 1.72
Genetic transformation of Rhodopseudomonas sphaeroides by plasmid DNA. J Bacteriol (1982) 1.60
Expression Vector for Zymomonas mobilis. Appl Environ Microbiol (1987) 1.41
Replication and conjugative mobilization of broad host-range IncQ plasmids. Plasmid (2009) 1.26
Versatile cloning vector for Pseudomonas aeruginosa. J Bacteriol (1981) 1.22
Transformation and mobilization of cloning vectors in Acinetobacter spp. J Bacteriol (1986) 1.07
Expression of pertussis toxin in Bordetella bronchiseptica and Bordetella parapertussis carrying recombinant plasmids. Infect Immun (1989) 1.00
Deletion plasmids from transformants of Pseudomonas aeruginosa trp cells with the RSF1010-trp hybrid plasmid and high levels of enzyme activity from the gene on the plasmid. J Bacteriol (1978) 0.99
Isolation of a DNA fragment containing replication functions from IncP2 megaplasmid pMG2. J Bacteriol (1985) 0.96
Construction of tn3-containing plasmids from plant-pathogenic pseudomonads and an examination of their biological properties. Appl Environ Microbiol (1985) 0.85
Transformation of Azotobacter vinelandii with plasmids RP4 (IncP-1 group) and RSF1010 (IncQ group). J Bacteriol (1981) 0.85
Tn3 labeling of a cryptic plasmid found in the plant pathogenic bacterium Pseudomonas tabaci and mobilization of RSF1010 by donation. J Bacteriol (1983) 0.80
Cpf1 Is A Versatile Tool for CRISPR Genome Editing Across Diverse Species of Cyanobacteria. Sci Rep (2016) 0.75
Acetylornithinase of Escherichia coli: partial purification and some properties. J Biol Chem (1956) 93.84
Circular DNA forms of colicinogenic factors E1, E2 and E3 from Escherichia coli. J Mol Biol (1968) 23.73
Molecular nature of two nonconjugative plasmids carrying drug resistance genes. J Bacteriol (1974) 8.42
Bacterial genome sizes determined by DNA renaturation studies. J Gen Microbiol (1970) 5.86
Plasmids in Pseudomonas. Annu Rev Genet (1976) 5.84
Map of plasmid RP4 derived by insertion of transposon C. J Mol Biol (1977) 3.00
Transformation of Pseudomonas putida and Escherichia coli with plasmid-linked drug-resistance factor DNA. Proc Natl Acad Sci U S A (1975) 2.35
Control of tryptophan synthetase amplified by varying the numbers of composite plasmids in Escherichia coli cells. Gene (1977) 1.58
In vitro construction of different oligomeric forms of lambdadv DNA and studies of their transforming activities. J Virol (1975) 1.39
Derepression of E. coli trp operon on interfamilial transfer. Nature (1977) 1.38
Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science (1998) 11.90
HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. Science (1992) 8.68
Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci U S A (1994) 6.93
Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science (1992) 5.99
DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev (1997) 5.76
Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J Exp Med (1994) 5.67
Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J Immunol (1995) 4.31
Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53. Mol Cell Biol (1992) 3.68
Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J (1999) 3.46
Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. Science (1992) 3.39
Isolation and characterization of linear deoxyribonucleic acid plasmids from Kluyveromyces lactis and the plasmid-associated killer character. J Bacteriol (1981) 3.30
Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41. J Cell Biol (1998) 3.23
Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. Proc Natl Acad Sci U S A (1997) 3.19
High-resolution structure of the oligomerization domain of p53 by multidimensional NMR. Science (1994) 2.98
Refined solution structure of the oligomerization domain of the tumour suppressor p53. Nat Struct Biol (1995) 2.75
Isolation and characterization of four plasmids from Bacillus subtilis. J Bacteriol (1977) 2.59
Clonal rat parathyroid cell line expresses a parathyroid hormone-related peptide but not parathyroid hormone itself. Biochem Biophys Res Commun (1989) 2.15
Definition of specific peptide motifs for four major HLA-A alleles. J Immunol (1994) 2.11
A novel oncogene, ost, encodes a guanine nucleotide exchange factor that potentially links Rho and Rac signaling pathways. EMBO J (1994) 2.09
Molecular interactions between interferon consensus sequence binding protein and members of the interferon regulatory factor family. Proc Natl Acad Sci U S A (1994) 1.98
Curing of the killer deoxyribonucleic acid plasmids of Kluyveromyces lactis. J Bacteriol (1981) 1.97
Intergeneric transfer of deoxyribonucleic acid killer plasmids, pGKl1 and pGKl2, from Kluyveromyces lactis into Saccharomyces cerevisiae by cell fusion. J Bacteriol (1981) 1.97
Structures of mollusc shell framework proteins. Nature (1997) 1.80
A linear DNA plasmid from Streptomyces rochei with an inverted terminal repetition of 614 base pairs. EMBO J (1984) 1.69
Napsin A, a member of the aspartic protease family, is abundantly expressed in normal lung and kidney tissue and is expressed in lung adenocarcinomas. FEBS Lett (1999) 1.68
Analysis of linear plasmids isolated from Streptomyces: association of protein with the ends of the plasmid DNA. Plasmid (1982) 1.67
Formation of multicellular spheroids composed of adult rat hepatocytes in dishes with positively charged surfaces and under other nonadherent environments. Exp Cell Res (1990) 1.66
Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. N Engl J Med (1989) 1.64
High-resolution three-dimensional structure of a single zinc finger from a human enhancer binding protein in solution. Biochemistry (1990) 1.64
Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant. Science (1992) 1.63
An efficient and cost-effective isotope labeling protocol for proteins expressed in Escherichia coli. J Biomol NMR (1998) 1.61
Transformation of Saccharomyces cerevisiae with linear DNA killer plasmids from Kluyveromyces lactis. J Bacteriol (1982) 1.61
Isolation of extrachromosomal deoxyribonucleic acids from extremely thermophilic bacteria. J Gen Microbiol (1978) 1.59
Control of tryptophan synthetase amplified by varying the numbers of composite plasmids in Escherichia coli cells. Gene (1977) 1.58
Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth. J Exp Med (1998) 1.57
dE2F2, a novel E2F-family transcription factor in Drosophila melanogaster. Biochem Biophys Res Commun (1998) 1.54
Xylose (glucose) isomerase gene from the thermophile Thermus thermophilus: cloning, sequencing, and comparison with other thermostable xylose isomerases. J Bacteriol (1991) 1.51
Kluyveromyces lactis killer toxin inhibits adenylate cyclase of sensitive yeast cells. Nature (1983) 1.50
Preclinical Cushing's syndrome due to adrenocorticotropin-independent bilateral adrenocortical macronodular hyperplasia with concurrent excess of gluco- and mineralocorticoids. Intern Med (1997) 1.49
Cloning of Bacillus subtilis leucina A, B and C genes with Escherichia coli plasmids and expression of the leuC gene in E. coli. Mol Gen Genet (1978) 1.47
The ezrin-like family of tyrosine kinase substrates: receptor-specific pattern of tyrosine phosphorylation and relationship to malignant transformation. Oncogene (1993) 1.44
Identification of subdominant CTL epitopes of the GP100 melanoma-associated tumor antigen by primary in vitro immunization with peptide-pulsed dendritic cells. J Immunol (1997) 1.43
mus308 mutants of Drosophila exhibit hypersensitivity to DNA cross-linking agents and are defective in a deoxyribonuclease. Genetics (1990) 1.42
Cloning of a new gene encoding an antigen recognized by melanoma-specific HLA-A24-restricted tumor-infiltrating lymphocytes. J Immunol (1995) 1.39
Derepression of E. coli trp operon on interfamilial transfer. Nature (1977) 1.38
Grb2/Ash binds directly to tyrosines 1068 and 1086 and indirectly to tyrosine 1148 of activated human epidermal growth factor receptors in intact cells. J Biol Chem (1994) 1.38
Tyrosines 1148 and 1173 of activated human epidermal growth factor receptors are binding sites of Shc in intact cells. J Biol Chem (1994) 1.37
Characteristics of endogenous peptides eluted from the class I MHC molecule HLA-B7 determined by mass spectrometry and computer modeling. J Immunol (1993) 1.33
Characterization of a novel killer toxin encoded by a double-stranded linear DNA plasmid of Kluyveromyces lactis. Eur J Biochem (1984) 1.32
Genetic characterization of parthenogenic Fasciola sp. in Japan on the basis of the sequences of ribosomal and mitochondrial DNA. Parasitology (2005) 1.31
Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor. J Biol Chem (1992) 1.29
Identification of a tyrosinase epitope recognized by HLA-A24-restricted, tumor-infiltrating lymphocytes. J Immunol (1995) 1.29
Phosphorylation of p53: a novel pathway for p53 inactivation in human T-cell lymphotropic virus type 1-transformed cells. J Virol (1998) 1.28
The DNA replication-related element (DRE)/DRE-binding factor system is a transcriptional regulator of the Drosophila E2F gene. J Biol Chem (1998) 1.27
Structural characterization of a 39-residue synthetic peptide containing the two zinc binding domains from the HIV-1 p7 nucleocapsid protein by CD and NMR spectroscopy. FEBS Lett (1991) 1.26
Specific sequences from the carboxyl terminus of human p53 gene product form anti-parallel tetramers in solution. Proc Natl Acad Sci U S A (1994) 1.25
DNA-dependent protein kinase is not required for the p53-dependent response to DNA damage. Nature (1999) 1.25
Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumor growth. Blood (1999) 1.25
Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles. J Immunol (1998) 1.24
Specific acetylation of chromosomal protein HMG-17 by PCAF alters its interaction with nucleosomes. Mol Cell Biol (1999) 1.21
Naturally processed peptides longer than nine amino acid residues bind to the class I MHC molecule HLA-A2.1 with high affinity and in different conformations. J Immunol (1994) 1.19
Three-dimensional solution structure of the E3-binding domain of the dihydrolipoamide succinyltransferase core from the 2-oxoglutarate dehydrogenase multienzyme complex of Escherichia coli. Biochemistry (1992) 1.19
High-resolution solution structure of the double Cys2His2 zinc finger from the human enhancer binding protein MBP-1. Biochemistry (1992) 1.19
Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type. Aliment Pharmacol Ther (2007) 1.19
Interaction of Shc with adaptor protein adaptins. J Biol Chem (1996) 1.18
Construction of a recombinant plasmid composed of B. subtilis leucine genes and a B. subtilis (natto) plasmid: its use as cloning vehicle in B. subtilis 168. Mol Gen Genet (1978) 1.17
Continued high albumin production by multicellular spheroids of adult rat hepatocytes formed in the presence of liver-derived proteoglycans. Biochem Biophys Res Commun (1989) 1.17
Transcriptional regulation of the Drosophila CycA gene by the DNA replication-related element (DRE) and DRE binding factor (DREF). Nucleic Acids Res (1996) 1.14
Interhelical angles in the solution structure of the oligomerization domain of p53: correction. Science (1995) 1.13
Xylose (glucose) isomerase gene from the thermophile Clostridium thermohydrosulfuricum; cloning, sequencing, and expression in Escherichia coli. Agric Biol Chem (1991) 1.13
A genetic and molecular analysis of DNA repair in Drosophila. J Cell Sci Suppl (1987) 1.12
Addition of mononucleotides to oligoribonucleotide acceptors with T4 RNA ligase. Proc Natl Acad Sci U S A (1978) 1.12
An evidence-based perspective on vitamin D and the growing skeleton. Osteoporos Int (2014) 1.12
Purification and characterization of a DNA polymerase beta from Drosophila*. J Biol Chem (1985) 1.11
Cloning and expression of the leucine gene from Thermus thermophilus in Escherichia coli. Gene (1980) 1.11
The high-resolution structure of the peripheral subunit-binding domain of dihydrolipoamide acetyltransferase from the pyruvate dehydrogenase multienzyme complex of Bacillus stearothermophilus. J Mol Biol (1993) 1.10
Heparin binding and oligomerization of hepatocyte growth factor/scatter factor isoforms. Heparan sulfate glycosaminoglycan requirement for Met binding and signaling. J Biol Chem (1997) 1.09
Analysis of mutations in cyclodextrin glucanotransferase from Bacillus stearothermophilus which affect cyclization characteristics and thermostability. J Bacteriol (1992) 1.07
The search for drug target molecules from genomics. BJU Int (2001) 1.07
A spectrophotometric assay for the cyclization activity of cyclomaltohexaose (alpha-cyclodextrin) glucanotransferase. Anal Biochem (1989) 1.07
Sulfoquinovosyldiacylglycerol, KM043, a new potent inhibitor of eukaryotic DNA polymerases and HIV-reverse transcriptase type 1 from a marine red alga, Gigartina tenella. Chem Pharm Bull (Tokyo) (1998) 1.07
Mutations in a putative agonist binding region of the AMPA-selective glutamate receptor channel. FEBS Lett (1992) 1.06
Human p53 is phosphorylated on serines 6 and 9 in response to DNA damage-inducing agents. J Biol Chem (2000) 1.06
Direct identification of an endogenous peptide recognized by multiple HLA-A2.1-specific cytotoxic T cells. Proc Natl Acad Sci U S A (1993) 1.06
Potent immunogenic short linear peptide constructs composed of B cell epitopes and Pan DR T helper epitopes (PADRE) for antibody responses in vivo. Vaccine (1997) 1.05
Vectors for gene cloning in Pseudomonas and their applications. Curr Top Microbiol Immunol (1982) 1.05
Fatty acids selectively inhibit eukaryotic DNA polymerase activities in vitro. Biochim Biophys Acta (1996) 1.04
The inhibitory action of fatty acids on DNA polymerase beta. Biochim Biophys Acta (1997) 1.03
Syk-independent tyrosine phosphorylation and association of the protein tyrosine phosphatases SHP-1 and SHP-2 with the high affinity IgE receptor. J Immunol (1997) 1.03
Mutational analysis of Lck in CD45-negative T cells: dominant role of tyrosine 394 phosphorylation in kinase activity. Mol Cell Biol (1996) 1.03
Calcium-dependent interaction of S100B with the C-terminal domain of the tumor suppressor p53. J Biol Chem (1999) 1.02
Definition of a DQ3.1-specific binding motif. J Immunol (1994) 1.01
Clinical characteristics of fulminant-type autoimmune hepatitis: an analysis of eleven cases. Aliment Pharmacol Ther (2006) 1.00
A new DNA polymerase species from Drosophila melanogaster: a probable mus308 gene product. Mutat Res (1999) 0.99
Deletion plasmids from transformants of Pseudomonas aeruginosa trp cells with the RSF1010-trp hybrid plasmid and high levels of enzyme activity from the gene on the plasmid. J Bacteriol (1978) 0.99